Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep552 | Pituitary and Neuroendocrinology | ECE2021

A complex case of refractory hypercalcaemia, end-stage diabetic nephropathy with pituitary mass and hypopituitarism– is there a unifying diagnosis?

Fennell David , Holland John A , Corkery Laura , Ludgate Stephen , McQuaid Siobhan

A 54-year-old female presented with one week of weakness, fatigue, headache, worsening constipation, and general malaise. Background history included long-standing type 1 diabetes (glutamic acid decarboxylase positive), on continuous subcutaneous insulin infusion, proliferative diabetic retinopathy, end-stage diabetic nephropathy on haemodialysis and subclinical hypothyroidism. Tertiary hyperparathyroidism was diagnosed (adjusted calcium 2.82 mmol/l, phosphate 1.42 mmol/l, par...

ea0073aep728 | Thyroid | ECE2021

A case of Graves’ disease (GD) associated with HIV disease and late immune reconstitution inflammatory syndrome (IRIS) following initiation of antiretroviral therapy (ART)

Ludgate Stephen , P Connolly Stephen , Fennell David , McQuaid Siobhan

GD following ART occurs rarely, in 3% of HIV-infected women1. It is suggested that CD4 cells increase in a biphasic pattern following ART initiation, with the expansion of naïve CD4 cells following months after the initial redistribution of memory CD4 cells from lymphoid tissue2. A 40-year-old Brazilian lady was diagnosed with HIV in late 2016 following admission with cryptococcal meningitis and salmonellosis, requiring treatment with anti-fungal age...

ea0056p472 | Diabetes complications | ECE2018

An assessment of abnormal liver function tests in a cohort of unselected diabetic patients

Ludgate Stephen , Naimimohasses Sara , Redha Mostafa , Crowley Vivian , Norris Suzanne , Healy Marie-Louise

Introduction: The prevalence of abnormal liver function tests (LFTs) in the general population has been estimated to be 8.1–9.8%. Abnormal LFTs are common in diabetes although there are still few studies describing the exact prevalence. AST-to-platelet-ratio-index (APRI) and Fibrosis-4-score (FIB4) are scoring systems which can be used to estimate the degree of liver fibrosis. An APRI score >1 has a sensitivity of 76% and a specificity of 72% for predicting cirrhosis ...

ea0059p088 | Diabetes & cardiovascular | SFEBES2018

Assessment of liver imaging in a diabetic population with an abnormal AST-to-platelet-ratio-index (APRI) or Fibrosis-4-score (FIB4)

Ludgate Stephen , Steen Julie , Divilly Patrick , Naimimohasses Sara , Kennedy Carmel , Pazderska Agnieszka , Phelan Niamh , Norris Suzanne , Healy Marie Louise

We conducted a retrospective study examining the prevalence of abnormal liver function tests (LFTs) in a diabetic population attending a tertiary referral centre and APRI and FIB4 scores were also calculated where possible. APRI and FIB4 scores can be used to estimate degree of liver fibrosis. APRI score >1 has 76% sensitivity, 72% specificity for predicting cirrhosis. APRI score >0.7 has 77% sensitivity, 72% specificity for predicting significant fibrosis. A FIB4 scor...